Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PCPC, FDA Negotiate Oversight Bill With Possible State-Law Preemption

Executive Summary

While acknowledging that there is “a long, long way to go,” PCPC’s John Hurson says industry and FDA have reached a tentative framework for legislation that would update federal cosmetics regulations and possibly preempt state laws, which have become the bane of national cosmetics manufacturers.


Related Content

FDA Abandons Negotiations With Cosmetics Industry On Legislative Plan
Regulatory Uniformity In U.S. Top Priority For ICMAD
Top Stories Of 2013: Retailers, Firms Self-Regulate As Consumer Power Grows
PCPC Reaffirms Commitment To FDA Negotiations On Regulatory Overhaul
FDA Shutdown Lands Hard On CFSAN-Regulated Industries
ICCR Ushers Forth Updated Cosmetic GMP Guidelines From FDA
Safe Cosmetics Act Launches, Aimed At “Regulatory Black Hole”



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts